Oppenheimer Maintains Outperform on NuCana, Adjusts Price Target To $150 from $4 (1-for-25 Reverse Stock Split)
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Leland Gershell maintains an Outperform rating on NuCana (NASDAQ:NCNA) and adjusts the price target to $150 from $4 following a 1-for-25 reverse stock split.
July 22, 2024 | 5:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer has maintained an Outperform rating on NuCana and adjusted the price target to $150 from $4 following a 1-for-25 reverse stock split.
The maintenance of an Outperform rating and a significant adjustment in the price target by Oppenheimer is a positive signal for investors. The reverse stock split consolidates shares, potentially making the stock more attractive to institutional investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100